The Hon. Greg Hunt MP
Minister for Health
Sarah Henderson MP
Federal Member for Corangamite
The Turnbull Government has announced in the 2018-19 Budget the listing of a life-changing breast cancer medicine on the Pharmaceutical Benefits Scheme that would otherwise cost patients around $71,820 per year.
Federal Member for Corangamite this investment of $703.6 million, will mean that more than 3,000 Australian patients with inoperable or metastatic hormone receptor positive breast cancer will benefit from the 1 July listing of ribociclib (Kisqali®).
“Hormone receptor positive tumours are the most common form of breast cancer and account for most of the deaths from the disease” Ms Henderaon said.
Minister for Health Greg Hunt said by inhibiting two proteins that drive the growth of tumour cells, ribociclib — used in combination with other drugs — will slow the progression of inoperable and metastatic breast cancers in some patients.
The independent Pharmaceutical Benefits Advisory Committee (PBAC) recommended the listing of Kisqali.
The Committee is by law and in practice, independent of Government in its deliberations. By law the Federal Government cannot list a new medicine without a positive recommendation from this committee.
Ms Henderson said since coming into Government, the Coalition has helped improve the health of Australians by subsidising approximately $9 billion worth of new medicines.
“Unlike Labor, we are subsidising all drugs recommended by the PBAC” Ms Henderson said.
“Labor delayed the listing of seven vital drugs – leaving important medicines out of reach for many Australian patients.”
Minister for Health Greg Hunt said our commitment to the PBS is rock solid.
“Together with Medicare, it is a foundation of our world-class health care system,” Minister Hunt said.
Sarah was pleased to join two local breast cancer fund raising events over the weekend.
The Ocean Grove Football and Netball Club held a Pink Day High Tea in support of the Breast Cancer Network Australia. People from across the community attended this very worthwhile event.
In its 21st year, the Mother’s Day Classic was held last Sunday around Australia including in Geelong. Sarah once again donned pink and joined runners and walkers supporting the Mother’s Day Classic Foundation and the National Breast Cancer Foundation.
“These two fantastic community events highlight that breast cancer is a broad medical issue which many women and families unfortunately need to face. Adding ribociclib (Kisqali®) to the PBS will make a very substantial difference.”
16 May 2018